Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.50
-1.01-5.18%
Pre-Market: 9:27 AM EDT
Comments
Loading...
Instil Bio Analyst Ratings and Price Targets | NASDAQ:TIL | Benzinga
Instil Bio Inc has a consensus price target of $61 based on the ratings of 9 analysts. The high is $180 issued by Baird on September 16, 2024. The low is $2 issued by Morgan Stanley on December 12, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Jefferies, and HC Wainwright & Co. on March 5, 2025, January 7, 2025, and November 18, 2024, respectively. With an average price target of $90.67 between HC Wainwright & Co., Jefferies, and HC Wainwright & Co., there's an implied 390.09% upside for Instil Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
Baird
Truist Securities
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Instil Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/05/2025 | Buy Now | 494.59% | HC Wainwright & Co. | Mitchell Kapoor45% | $110 → $110 | Reiterates | Buy → Buy | Get Alert |
| 02/13/2025 | Buy Now | — | JMP Securities | Chris Muller60% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 01/07/2025 | Buy Now | 181.08% | Jefferies | Kelly Shi41% | $11 → $52 | Upgrade | Hold → Buy | Get Alert |
| 11/18/2024 | Buy Now | 494.59% | HC Wainwright & Co. | Mitchell Kapoor45% | $110 → $110 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2024 | Buy Now | 494.59% | HC Wainwright & Co. | Mitchell Kapoor45% | $120 → $110 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | — | JMP Securities | Reni Benjamin45% | — | Initiates | → Market Perform | Get Alert |
| 09/17/2024 | Buy Now | 548.65% | HC Wainwright & Co. | Mitchell Kapoor45% | $120 → $120 | Reiterates | Buy → Buy | Get Alert |
| 09/16/2024 | Buy Now | 548.65% | HC Wainwright & Co. | Mitchell Kapoor45% | $40 → $120 | Maintains | Buy | Get Alert |
| 09/16/2024 | Buy Now | 872.97% | Baird | Jack Allen 36% | $180 → $180 | Reiterates | Outperform → Outperform | Get Alert |
| 09/13/2024 | Buy Now | 872.97% | Baird | Jack Allen 36% | $32 → $180 | Maintains | Outperform | Get Alert |
| 09/12/2024 | Buy Now | 116.22% | HC Wainwright & Co. | Mitchell Kapoor45% | $25 → $40 | Maintains | Buy | Get Alert |
| 08/23/2024 | Buy Now | 35.14% | HC Wainwright & Co. | Mitchell Kapoor45% | $18 → $25 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | -2.7% | HC Wainwright & Co. | Mitchell Kapoor45% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | -2.7% | HC Wainwright & Co. | Mitchell Kapoor45% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 72.97% | Baird | Jack Allen 36% | $54 → $32 | Maintains | Outperform | Get Alert |
| 04/12/2024 | Buy Now | -40.54% | Jefferies | Kelly Shi41% | $5 → $11 | Downgrade | Buy → Hold | Get Alert |
| 03/25/2024 | Buy Now | -2.7% | HC Wainwright & Co. | Mitchell Kapoor45% | $18 → $18 | Reiterates | Buy → Buy | Get Alert |
| 01/22/2024 | Buy Now | -2.7% | HC Wainwright & Co. | Mitchell Kapoor45% | $2 → $18 | Maintains | Buy | Get Alert |
| 01/19/2024 | Buy Now | 191.89% | Baird | Jack Allen 36% | → $54 | Reiterates | Outperform → Outperform | Get Alert |
| 01/17/2024 | Buy Now | 191.89% | Baird | Jack Allen 36% | $100 → $54 | Maintains | Outperform | Get Alert |
| 11/14/2023 | Buy Now | -89.19% | HC Wainwright & Co. | Mitchell Kapoor45% | → $40 | Reiterates | Buy → Buy | Get Alert |
| 08/17/2023 | Buy Now | -89.19% | HC Wainwright & Co. | Mitchell Kapoor45% | → $40 | Reiterates | Buy → Buy | Get Alert |
| 06/29/2023 | Buy Now | -89.19% | HC Wainwright & Co. | Mitchell Kapoor45% | → $40 | Initiates | → Buy | Get Alert |
| 04/05/2023 | Buy Now | -67.57% | Truist Securities | Asthika Goonewardene41% | → $120 | Reinstates | → Hold | Get Alert |
| 12/12/2022 | Buy Now | -89.19% | Morgan Stanley | Vikram Purohit38% | $120 → $40 | Maintains | Equal-Weight | Get Alert |
| 11/17/2022 | Buy Now | -24.32% | Baird | Jack Allen 36% | $480 → $280 | Maintains | Outperform | Get Alert |
| 11/01/2022 | Buy Now | -67.57% | Morgan Stanley | Vikram Purohit38% | $160 → $120 | Maintains | Equal-Weight | Get Alert |
| 11/01/2022 | Buy Now | 29.73% | Baird | Jack Allen 36% | $620 → $480 | Maintains | Outperform | Get Alert |
| 11/01/2022 | Buy Now | — | Cowen & Co. | Yaron Werber35% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/06/2022 | Buy Now | 67.57% | Baird | Jack Allen 36% | $680 → $620 | Maintains | Outperform | Get Alert |
| 08/24/2022 | Buy Now | -56.76% | Morgan Stanley | Vikram Purohit38% | $180 → $160 | Maintains | Equal-Weight | Get Alert |
| 08/23/2022 | Buy Now | -13.51% | Truist Securities | Robyn Karnauskas56% | $500 → $320 | Maintains | Buy | Get Alert |
| 06/06/2022 | Buy Now | -51.35% | Morgan Stanley | Vikram Purohit38% | $280 → $180 | Maintains | Equal-Weight | Get Alert |
| 05/24/2022 | Buy Now | -24.32% | Morgan Stanley | Vikram Purohit38% | $300 → $280 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Instil Bio (TIL) stock?
The latest price target for Instil Bio (NASDAQ:TIL) was reported by HC Wainwright & Co. on March 5, 2025. The analyst firm set a price target for $110.00 expecting TIL to rise to within 12 months (a possible 494.59% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Instil Bio (TIL)?
The latest analyst rating for Instil Bio (NASDAQ:TIL) was provided by HC Wainwright & Co., and Instil Bio reiterated their buy rating.
When was the last upgrade for Instil Bio (TIL)?
The last upgrade for Instil Bio Inc happened on January 7, 2025 when Jefferies raised their price target to $52. Jefferies previously had a hold for Instil Bio Inc.
When was the last downgrade for Instil Bio (TIL)?
The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.
When is the next analyst rating going to be posted or updated for Instil Bio (TIL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on March 5, 2025 so you should expect the next rating to be made available sometime around March 5, 2026.
Is the Analyst Rating Instil Bio (TIL) correct?
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a reiterated with a price target of $110.00 to $110.00. The current price Instil Bio (TIL) is trading at is $18.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.